0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 321-340 of 497 Articles
Research Letters |  FREE
Christine M. Cheng, PharmD; B. Joseph Guglielmo, PharmD; Judy Maselli, MSPH; et al.
Arch Intern Med. 2010;170(9):831-833. doi:10.1001/archinternmed.2010.91.

Invited Commentary | 
Julie Kliger, BA, BSN, MPA
Arch Intern Med. 2010;170(8):690-692. doi:10.1001/archinternmed.2010.58.

Original Investigation |  FREE
Johanna I. Westbrook, PhD; Amanda Woods, RN, MEd; Marilyn I. Rob, PhD; et al.
Arch Intern Med. 2010;170(8):683-690. doi:10.1001/archinternmed.2010.65.
Includes: CME

Editor's Correspondence | 
Surrey M. Walton, PhD; Glen T. Schumock, PharmD, MBA; G. Caleb Alexander, MD, MS; et al.
Arch Intern Med. 2010;170(7):657-658. doi:10.1001/archinternmed.2010.69.

Editor's Correspondence | 
Michael T. Rupp, PhD, RPh
Arch Intern Med. 2010;170(7):658. doi:10.1001/archinternmed.2010.70.

Editor's Correspondence | 
Emily A. Largent, BS; Franklin G. Miller, PhD; Steven D. Pearson, MD, MSc
Arch Intern Med. 2010;170(7):658. doi:10.1001/archinternmed.2010.71.

Original Investigation |  FREE
Stephen D. Persell, MD, MPH; Charles Zei; Kenzie A. Cameron, PhD, MPH; et al.
Arch Intern Med. 2010;170(5):470-477. doi:10.1001/archinternmed.2009.525.

Original Investigation |  FREE
Laura L. Loertscher, MD, MPH; Andrew J. Halvorsen, MS; Brent W. Beasley, MD; et al.
Arch Intern Med. 2010;170(4):356-362. doi:10.1001/archinternmed.2009.524.

Commentary | 
Emily A. Largent, BS; Franklin G. Miller, PhD; Steven D. Pearson, MD, MS
Arch Intern Med. 2009;169(19):1745-1747. doi:10.1001/archinternmed.2009.314.

Editor's Correspondence | 
Sudeep S. Gill, MD, MSc; Chaim M. Bell, MD, PhD; Paula A. Rochon, MD, MPH
Arch Intern Med. 2009;169(18):1718-1725. doi:10.1001/archinternmed.2009.348.

Editor's Correspondence | 
J. David Baxter, MD
Arch Intern Med. 2009;169(18):1718-1725. doi:10.1001/archinternmed.2009.349.

Clinical Observation | 
Saul N. Weingart, MD, PhD; Brett Simchowitz, BA; Lawrence Shiman, MPP; et al.
Arch Intern Med. 2009;169(17):1627-1632. doi:10.1001/archinternmed.2009.300.

Original Investigation |  FREE
Saul N. Weingart, MD, PhD; Brett Simchowitz, BA; Harper Padolsky, MD; et al.
Arch Intern Med. 2009;169(16):1465-1473. doi:10.1001/archinternmed.2009.252.
Includes: Supplemental Content

Invited Commentary | 
Daniel S. Budnitz, MD, MPH
Arch Intern Med. 2009;169(14):1332-1334. doi:10.1001/archinternmed.2009.180.

Editor's Correspondence | 
Michelle Sweidan, BPharm, MPH; James F. Reeve, BPharm, PhD; Jonathan G. A. Dartnell, BPharm, PhD
Arch Intern Med. 2009;169(14):1336-1340. doi:10.1001/archinternmed.2009.225.

Editor's Correspondence | 
Thomas Issaac, MD, MPH, MBA; Joel S. Weissman, PhD; Roger B. Davis, ScD; et al.
Arch Intern Med. 2009;169(14):1336-1340. doi:10.1001/archinternmed.2009.226.

Original Investigation |  FREE
Michael A. Steinman, MD; Gary E. Rosenthal, MD; C. Seth Landefeld, MD; et al.
Arch Intern Med. 2009;169(14):1326-1332. doi:10.1001/archinternmed.2009.206.

Other Articles | 
Arch Intern Med. 2009;169(13):1184. doi:10.1001/archinternmed.2009.143.

Research Letters |  FREE
Andrew R. Miesner, PharmD; Daniel P. Allen, MD; Carrie F. Koenigsfeld, PharmD; et al.
Arch Intern Med. 2009;169(13):1241-1247. doi:10.1001/archinternmed.2009.171.

Editor's Correspondence | 
Arch Intern Med. 2009;169(11):1069-1081. doi:10.1001/archinternmed.2009.148.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA
Viewpoint  | 
Educational Opportunities With Postevent Debriefing
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.